Rigorous selection

Whenever applicable, an application should pertinently address the following criteria on which the evaluation will be based (weighting factor between brackets 1 Low-3 High):

1. Unmet medical need that will be addressed (3)
2. Management (3)
3. Market potential/competitor advantage (3)
4. Valorisation strategy (3)
5. Technological validation or preclinical proof of concept (3)
6. Intellectual Property (IP): at least a Freedom To Operate or strategy (3)
7. Match funding secured or strategy to do so (2)
8. Access to quality samples (retrospective studies) or clinicians (prospective studies) with a clear presentation of IP aspects related to such collaboration (3)
9. Access to bio statistical expertise (2)
10. Access to industrial assay/device development & testing skills: both internal quality control measures and external quality assurance (2)
11. Regulatory strategy (2)
12. Planning and budget accuracy (2)
13. Risk appraisal (success/failure ratio) according to existing data (2)
14. Competition mapping (2)